Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A longitudinal study to investigate innate immune reprogramming following Herpes Zoster vaccinatio... Read More
U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07894952) titled 'Implementing IVM for Fertility Treatment in Clinical Practice' on Oct. 07. Brief Summary: ... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'Phase I/II study of Mezigdomide and Elranatamab for relapsed/refractory multiple myeloma patients ... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'Phase Ib/II Study of Tislelizumab in Combination with Bevacizumab and Capecitabine in Advanced Sol... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose St... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Multicenter, Open-Label, First-in-Human Study to Evaluate the Safety, Tolerability, Pha... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating ... Read More
U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07893795) titled 'A Clinical Trial to Evaluate the Effects of the NeuEve Dryness Treatment Kit on Vaginal Hea... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Pla... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A multicenter, randomized, double-blind, placebo-controlled Phase 2 study to investigate the effic... Read More